Here are five takeaways:
1. An aging population, increasing number of patients with chronic back pain, rising awareness of chronic pain and a growing number of technologies will drive the market’s growth.
2. Cost and unfavorable reimbursement policies will serve as obstacles to the market’s growth.
3. North America and Europe hold the largest shares of the market.
4. Asia will experience the fastest market growth because of better reimbursement policies, a large population, more awareness of technologies and increased purchasing power of hospitals.
5. Medtronic, Stryker, Pioneer Surgical, NuVasive, DuPuy Spne, Globus Medical, K2M, Orhtofix International, TranS1, Amedica, Zimmer, LDR, Biomet Spine, Exactech, Integra LifeSciences, Alphatec Spine, Orthovita and Synthes lead the market.
More articles on devices:
Ellipse Technologies files $75M IPO: 4 takeaways
National Association of Professional Women honors NuVasive’s Heather Rossetti: 4 quick facts
Xtant Medical stock listed on NYSE MKT: 3 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
